LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-19
Case ID: NM_006218.4_c.3172A_T_20261119_203431
Framework: ACMG/AMP 2015
Variant classification summary

NM_006218.4:c.3172A>T

PIK3CA  · NP_006209.2:p.(Ile1058Phe)  · NM_006218.4
GRCh37: chr3:178952117 A>T  ·  GRCh38: chr3:179234329 A>T
Gene: PIK3CA Transcript: NM_006218.4
Final call
VUS
PS4 supporting PM1 supporting PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PIK3CA
Transcript
NM_006218.4
Protein
NP_006209.2:p.(Ile1058Phe)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
VUS: PS4 Supporting reflects 2.0 raw VCEP tumor-occurrence points, capped at Supporting.
2
VUS: PM1 Supporting places p.Ile1058Phe within the approved PIK3CA kinase domain at residues 797-1068.
3
VUS: PM2 Supporting reflects absence from the qualifying GNOMAD_V2_1 control dataset.
Final determination: Under ACMG/AMP 2015 Table 5, three supporting pathogenic criteria without any very strong, strong, or moderate criterion do not satisfy a pathogenic or likely pathogenic combination, so the call is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: the VCEP excludes PVS1 for this gene.
cspec
PS1 Not met Not met: no alternate-nucleotide p.I1058F variant independently established as pathogenic under BMVCEP criteria was identified.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1 PMID:17062663 PMID:33772212 PMID:31842489 PMID:39369133
PS2 Not assessed Not assessed: somatic tumor reports lack confirmed parental testing, a relevant affected-tissue proband, and documented CLIA-level high-confidence reporting required by the VCEP.
cspec PMID:17062663 PMID:33772212 PMID:31842489 PMID:39369133 vcep_clingen_brainmalform_acmg_specifications_v1_1
PS3 Not assessed Not assessed: the available p.I1058F reports contain no variant-specific functional assay meeting the VCEP's required validation-control and assay-acceptability criteria.
vcep_clingen_brainmalform_acmg_specifications_v1_1 PMID:17062663 PMID:33772212 PMID:31842489 PMID:39369133
PS4 Met Met at Supporting: COSMIC reports 8 tumor occurrences, corresponding to 2.0 raw Table 2A points, with tumor evidence capped by the VCEP at Supporting.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1 cosmic gnomad_v2 gnomad_canada gnomad_v4 PMID:17062663
PM1 Met Met at Supporting: residue 1058 falls within the VCEP-approved PIK3CA kinase-domain interval 797-1068.
vcep_clingen_brainmalform_acmg_specifications_v1_1 cspec
PM2 Met Met at Supporting: the variant is absent from GNOMAD_V2_1, satisfying the VCEP PM2 requirement of absent/rare controls with no more than one observation.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1 gnomad_v2
PM3 N/A Not applicable: the VCEP states disease-causing variants are heterozygous, so the recessive PM3 criterion is excluded.
vcep_clingen_brainmalform_acmg_specifications_v1_1
PM4 N/A Not applicable: the VCEP excludes PM4 for this gene.
cspec
PM5 Not met Not met: zero different missense substitutions at residue 1058 with an independent BMVCEP pathogenic determination were identified.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1 pm5_candidates PMID:17062663 PMID:33772212 PMID:31842489 PMID:39369133
PM6 N/A Not applicable: the VCEP directs that PM6 is addressed through PS2 and will not be used separately.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PP1 N/A Not applicable: the VCEP excludes PP1 for this disorder because disease-causing variants are germline mosaic, de novo, or mosaic.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PP2 Not assessed Not assessed: the required PIK3CA ExAC/gnomAD missense-constraint z-score is unavailable, so the >3.09 threshold cannot be evaluated.
cspec
PP3 N/A Not applicable: the VCEP excludes PP3 for gain-of-function variants, and c.3172A>T produces the missense change p.Ile1058Phe.
cspec
PP4 N/A Not applicable: the VCEP explicitly accounts phenotype specificity under PS4 rather than allowing an independent PP4 call.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PP5 N/A Not applicable: the VCEP states that PP5 is not for use under the ClinGen SVI VCEP Review Committee recommendation.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
BA1 Not assessed Not assessed: GNOMAD_V2_1 is absent, but GNOMAD_V4_1 frequency is unknown, so the >0.0926% BA1 threshold cannot be evaluated completely.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1 gnomad_v2 gnomad_v4
BS1 Not assessed Not assessed: GNOMAD_V2_1 is absent, but GNOMAD_V4_1 frequency is unknown, so the >0.0185% BS1 threshold cannot be evaluated completely.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1 gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: no homozygote count or well-phenotyped family observations are available to evaluate the VCEP requirement of at least three qualifying observations.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1 gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no variant-specific benign functional assay or VCEP-required validation controls were reported for p.I1058F.
vcep_clingen_brainmalform_acmg_specifications_v1_1 PMID:17062663 PMID:33772212 PMID:31842489 PMID:39369133
BS4 N/A Not applicable: the VCEP excludes BS4 because these disorders involve de novo, germline mosaic, or post-zygotic mutations.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
BP1 N/A Not applicable: the VCEP excludes BP1 because loss of function is not the disease mechanism for these disorders.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
BP2 Not assessed Not assessed: p.I1058F and p.R88Q co-occurred, but phase and the required pathogenic status of the same-gene partner were not established.
vcep_clingen_brainmalform_acmg_specifications_v1_1 PMID:39369133 PMID:33772212 PMID:17062663 PMID:31842489
BP3 N/A Not applicable: the VCEP excludes BP3 for this gene.
cspec
BP4 N/A Not applicable: BP4 is restricted to synonymous, qualifying intronic, or UTR variants, whereas c.3172A>T is an exonic missense change.
cspec
BP5 Not met Not met: available p.I1058F reports are somatic tumors and do not document a cerebral-malformation case with an alternate disease basis in a different gene.
cspec PMID:17062663 PMID:33772212 PMID:39369133 PMID:31842489
BP6 N/A Not applicable: the VCEP explicitly marks BP6 not applicable for this framework.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
BP7 N/A Not applicable: BP7 requires a synonymous, qualifying intronic, or UTR variant, but c.3172A>T is an exonic missense substitution.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.